INSTACARE for HIV Infection
(INSTACARE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to see if community health workers using mobile phones can help Black people with poorly controlled HIV manage their condition better.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Is INSTACARE safe for humans?
How is the INSTACARE drug different from other HIV treatments?
What data supports the effectiveness of the drug INSTACARE for HIV infection?
Who Is on the Research Team?
Sonjia Kenya, EdD
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for Black individuals aged 18 or older with poorly controlled HIV, who are patients at the University of Miami/Jackson Memorial Health System's adult HIV clinic. They must speak English and be identified by their clinician as having uncontrolled viral suppression.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the INSTACARE intervention, which includes a Community Health Worker (CHW) intervention and a mobile telehealth (M-Health) component, for three months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- INSTACARE
INSTACARE is already approved in European Union, United States for the following indications:
- HIV-1 infection
- HIV-1 infection
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator